Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Myeloid 1Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Colorectal Neoplasms 43Neoplasms 19Neoplasm Metastasis 17Rectal Neoplasms 12Colonic Neoplasms 10Carcinoma, Non-Small-Cell Lung 8Lung Neoplasms 5Head and Neck Neoplasms 3Carcinoma, Squamous Cell 3Carcinoma 3Recurrence 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Advanced Solid Tumors 2Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Solid Tumor, Adult 1Kidney Neoplasms 1Histiocytosis 1Gastrointestinal Neoplasms 1Exanthema 1Esophageal Neoplasms 1Colorectal Cancer Metastatic 1Brain Neoplasms 1

Interventions

Panitumumab 1PLX8394 1IFL protocol 1Gemcitabine 1Cetuximab 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Histiocytosis × Panitumumab × Clear all
NCT05786924 2026-04-21

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Servier

Phase 1/2 Recruiting
554 enrolled
CNSGastrointestinalHead & NeckMyeloidThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Histiocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡